United-Guardian Inc

United-Guardian Inc(UG)股票分析

$6.780

-0.020 (-0.29%)收盘时

Loading chart…
最高
6.885
开盘
6.690
成交量加权均价
6.77
成交量
16.51K
市值
42.64M
最低
6.650
成交额
111.82K
企业价值/息税折旧摊销前利润(TTM)
0.00

United-Guardian, Inc. is a manufacturer of cosmetic ingredients, sexual wellness ingredients, pharmaceuticals, and medical lubricants. The Company’s product lines include the Lubrajel line of multifunctional hydrogel formulations, which are designed to provide sensory enhancement, lubrication, hydration, and texture to both personal care and medical products. Its four distinct product categories include cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. Its COSMOS line of products includes Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural, and Lubrajel Terra. Its medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. The Company’s pharmaceutical products include an FDA-approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial.

u-g.com

AI 分析 of United-Guardian Inc (UG)

持有

United-Guardian Inc is currently not a strong buy due to mixed performance indicators. The current price is $6.78, with an RSI of 40.69 indicating a neutral momentum. The forward P/E ratio is 26.53, suggesting that the stock may be overvalued relative to its earnings potential. However, the company has shown a year-to-date change of +10.60%, indicating some resilience. The main risk is the recent revenue decline of 13.5% year-over-year, attributed to market challenges, which could impact future profitability.

估值指标

United-Guardian Inc(UG)当前预期市盈率为 26.53,5 年平均预期市盈率为 4.61。

预期市盈率

严重高估
5 年均值 P/E
4.61
当前P/E
26.53
高估
14.78
低估
-5.56

预期 EV/EBITDA

严重低估
5 年均值 EV/EBITDA
0.00
当前EV/EBITDA
0.00
高估
0.00
低估
0.00

预期市销率

严重低估
5 年均值 P/S
0.00
当前P/S
0.00
高估
0.00
低估
0.00

Alphio AI 对 UG 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%UG

$13.06

情景价格

基

基准

基准 · 50%UG

$11.05

情景价格

悲

悲观

悲观 · 25%UG

$10.96

情景价格

事件时间线

2025-11-06 (ET)

09:04:50

United-Guardian Announces Q3 Earnings Per Share of 6 Cents Compared to 19 Cents Last Year

2025-08-08 (ET)

09:05:14

United-Guardian reports Q2 EPS 14c vs 21c

2025-05-21 (ET)

09:05:44

United-Guardian appoints Donna Vigilante to board of directors

2025-05-08 (ET)

09:03:12

United-Guardian reports Q1 EPS 12c vs 20c last year

2025-03-21 (ET)

09:04:32

United-Guardian reports FY24 EPS 71c vs 56c last year

资讯

UG 常见问题 —— 由 Alphio AI 解答

United-Guardian, Inc. is a manufacturer of cosmetic ingredients, sexual wellness ingredients, pharmaceuticals, and medical lubricants. The Company’s product lines include the Lubrajel line of multifunctional hydrogel formulations, which are designed to provide sensory enhancement, lubrication, hydration, and texture to both personal care and medical products. Its four distinct product categories include cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. Its COSMOS line of products includes Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural, and Lubrajel Terra. Its medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. The Company’s pharmaceutical products include an FDA-approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial. It operates in the Healthcare sector (PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS industry).

United-Guardian Inc is currently not a strong buy due to mixed performance indicators. The current price is $6.78, with an RSI of 40.69 indicating a neutral momentum. The forward P/E ratio is 26.53, suggesting that the stock may be overvalued relative to its earnings potential. However, the company has shown a year-to-date change of +10.60%, indicating some resilience. The main risk is the recent revenue decline of 13.5% year-over-year, attributed to market challenges, which could impact future profitability.

暂无帖子

注册或登录后参与讨论

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易